You are here

Big Pharma seeks patients in India's remote corners

Companies taking a longer-term stance to understand the markets, hoping to capture market share in future

The Chinese spent US$116.7b on medicine in 2016. This may hit US$170b in 2021. Spending in India is forecast to grow at an even faster rate - from US$17.4b to as high as US$30b in the same period.


FIRST, foreign food brands flooded India with chips, cookies and soft drinks that fundamentally changed the nation's eating habits. Now, Big Pharma wants to cash in on an upsurge in cases of diabetes and heart disease in the country's most distant corners.


Market voices on: